project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZK; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.3; age at index: 68; days to birth: -24839; days to death: 728; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1937; year of death: 2006; age at diagnosis: 24839; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2009; initial weight: 210.0; oct embedded: false; preservation method: Unknown; sample id: 07e2fea3-4ba5-49b3-ae9b-61ff8492026c; sample submitter id: TCGA-FS-A1ZK-06A; portion id: 9e0163cc-a450-41c0-bf3e-d226401ba808; portion submitter id: TCGA-FS-A1ZK-06A-11; slide id: 9b01e07d-08c4-4271-9df1-1d64f3182416; slide submitter id: TCGA-FS-A1ZK-06A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 7.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 93.0; percent tumor nuclei: 92.0; section location: TOP;